The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
8-(Piperazin-1-yl)-3-propyl-6-(3,6,6-trimethyl-4-oxo-4,5,6,7-tetrahydro-1H-indazol-1-yl)isoquinolin-1(2H)-one ID: ALA4762355
PubChem CID: 149044810
Max Phase: Preclinical
Molecular Formula: C26H33N5O2
Molecular Weight: 447.58
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCCc1cc2cc(-n3nc(C)c4c3CC(C)(C)CC4=O)cc(N3CCNCC3)c2c(=O)[nH]1
Standard InChI: InChI=1S/C26H33N5O2/c1-5-6-18-11-17-12-19(13-20(24(17)25(33)28-18)30-9-7-27-8-10-30)31-21-14-26(3,4)15-22(32)23(21)16(2)29-31/h11-13,27H,5-10,14-15H2,1-4H3,(H,28,33)
Standard InChI Key: QIHNHECWQYHTKE-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 37 0 0 0 0 0 0 0 0999 V2000
5.8992 -26.5091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5093 -27.0644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6852 -26.2584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5815 -28.6676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8626 -28.2542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1510 -28.6674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8619 -27.4270 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4493 -26.1561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1945 -26.9431 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2766 -26.1554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5304 -26.9475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3388 -27.1229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6454 -25.7169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8313 -25.5386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5785 -24.7533 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9670 -25.4877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1600 -29.4894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1498 -31.1397 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8682 -29.9041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8625 -30.7249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5667 -31.1379 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2809 -30.7347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2866 -29.9139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5780 -29.4963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9920 -31.1531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7099 -30.7465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4209 -31.1649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4466 -29.9036 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7348 -29.4918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0235 -29.9026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0213 -30.7279 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7366 -31.1409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4542 -30.7284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
1 3 1 0
24 4 2 0
4 5 1 0
5 6 2 0
6 17 1 0
5 7 1 0
7 11 1 0
10 8 1 0
8 9 2 0
9 7 1 0
10 11 2 0
10 14 1 0
11 12 1 0
12 1 1 0
1 13 1 0
13 14 1 0
14 15 2 0
8 16 1 0
20 18 2 0
19 17 2 0
19 20 1 0
19 24 1 0
20 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
22 25 1 0
25 26 1 0
26 27 1 0
17 28 1 0
28 29 1 0
28 33 1 0
29 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 447.58Molecular Weight (Monoisotopic): 447.2634AlogP: 3.54#Rotatable Bonds: 4Polar Surface Area: 83.02Molecular Species: BASEHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.52CX Basic pKa: 8.81CX LogP: 2.94CX LogD: 1.52Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.64Np Likeness Score: -0.77
References 1. Mishra SJ,Liu W,Beebe K,Banerjee M,Kent CN,Munthali V,Koren J,Taylor JA,Neckers LM,Holzbeierlein J,Blagg BSJ. (2021) The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with pan-Hsp90 Inhibition., 64 (3.0): [PMID:33428418 ] [10.1021/acs.jmedchem.0c01700 ]